Q32 Bio Inc. — Director's Dealing 2023

Aug 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Homology Medicines, Inc. (FIXX)
CIK: 0001661998
Period of Report: 2023-08-02

Reporting Person: Jordan Julie (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-02	Common Stock	M	350	$0.00	Acquired	2869	Direct
2023-08-02	Common Stock	S	99	$1.31	Disposed	2770	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-02	Restricted Stock Units	$	M	350	Disposed		Common Stock (350)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

F2: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on September 14, 2021 solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units.

F3: The restricted stock units vested and settled in full on August 2, 2023.